This finding is in accordance with the result that nuclear respiratory factor 1 (NRF1), a transcription factor, is highly active in astrocytoma and can indirectly regulate the cell cycle by targeting ARMC5 to promote glioma proliferation (Bhawe et al., 2020). Here, ARMC5 is linked to central nervous system cancer.